VRTX (US) share price forecast & AI signal — Vertex Pharmaceuticals Incorporated
Week of 2026-10-30 · Healthcare
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in VRTX
Vertex Pharmaceuticals Incorporated is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a HOLD with moderate confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of...
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $547.09 |
| 2026-11-05 | $542.50 |
| 2026-11-04 | $549.04 |
| 2026-11-03 | $530.76 |
| 2026-11-02 | $553.15 |
| 2026-10-30 | $558.88 |
| 2026-10-29 | $540.00 |
VRTX FAQ
Is Vertex Pharmaceuticals Incorporated (VRTX) a buy or sell this week?
The ACE Stock Bots machine-learning model rates VRTX a HOLD for the week of 2026-10-30 with moderate confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for VRTX?
Every week the model scores VRTX across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Healthcare stocks on the US
This week's top US picks · All US stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.